Suchergebnisse - "Park, Chan Kwon"

PubPharm (80)

1

Impact of adjuvant chemotherapy on patients with stage IB non-small cell lung cancer with visceral pleural invasion

enthalten in: Journal of thoracic disease | 2024

von Kim, B. | Choi, J. | Lee, S. | +9

2

Real-world outcome of crizotinib for anaplastic lymphoma kinase-positive lung cancer : Multicenter retrospective analysis in South Korea

enthalten in: Thoracic cancer | 2024

von Jeon, D. | Park, C. | Kim, S. | +15

3

Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer

enthalten in: Cancers | 2024

von Kim, H. | Lee, J. | Oh, I. | +11

4

Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC)

enthalten in: Journal of experimental & clinical cancer research : CR | 2023

von Lee, S. | Cho, H. | Choi, J. | +20

ErratumIn: J Exp Clin Cancer Res. 2023 Dec 6;42(1):332. - PMID 38057916

5

Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non-Small Cell Lung Cancer : Updated Analysis of the RESET Study

enthalten in: Cancer research and treatment | 2023

von Kim, T. | Jang, T. | Choi, C. | +14

6

Optimal timing for local ablative treatment of bone oligometastases in non-small cell lung cancer

enthalten in: Journal of bone oncology | 2023

von Lee, J. | Kim, J. | An, T. | +7

7

Identification of predictive factors for early relapse in patients with unresectable stage III non-small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation therapy

enthalten in: Thoracic cancer | 2023

von Nam, J. | Yeo, C. | Park, C. | +7

8

Prediction of Postoperative Lung Function in Lung Cancer Patients Using Machine Learning Models

enthalten in: Tuberculosis and respiratory diseases | 2023

von Kwon, O. | Han, S. | Lee, H. | +8

9

Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis : survival and prognostic factors

enthalten in: Translational lung cancer research | 2023

von Kim, J. | Jang, T. | Choi, C. | +14

10

Bone-modifying agents for non-small-cell lung cancer patients with bone metastases during the era of immune checkpoint inhibitors : A narrative review

enthalten in: Seminars in oncology | 2023

von Kim, J. | Jeong, C. | Lee, J. | +7

1
2
3
4
5
6
7
8
Nächster »
[8]